Description
Updated settlement dates for offer to buy acquisition window for PHARMAIDS PHARMACEUTICALS LIMITED with revised obligation download and settlement dates.
Summary
BSE has revised the settlement schedule for the offer to buy acquisition window (takeover) of PHARMAIDS PHARMACEUTICALS LIMITED. The takeover period ran from August 4, 2025 to August 18, 2025, with updated obligation download and settlement dates.
Key Points
- Settlement No: 2025067
- Bid Period: August 4, 2025 to August 18, 2025
- Revised Obligation Download Date: August 22, 2025
- Revised Settlement Date: August 25, 2025
- Demat shares must be delivered through Early Pay-in of Shares mechanism
- Market Type “(Takeover)” and settlement No. 2025035 to be used in depository system
Regulatory Changes
No new regulatory changes introduced. This is a schedule revision for an existing takeover process.
Compliance Requirements
- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Must specify Market Type “(Takeover)” and settlement No. 2025035 in depository system
- Refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise Stamp Duty charges
- Follow guidelines per Notice No.20200528-32 dated May 28, 2020
Important Dates
- Bid Period: August 4-18, 2025
- Revised Obligation Download: August 22, 2025
- Revised Settlement Date: August 25, 2025
Impact Assessment
Medium impact limited to participants in PHARMAIDS PHARMACEUTICALS LIMITED takeover. The revised dates provide clarity for settlement obligations and ensure proper processing through the acquisition window mechanism. Members and custodians need to adjust their settlement processes accordingly.
Impact Justification
Settlement schedule revision affects takeover participants but limited to specific company